NCT00032305 - Research Study in Patients With Severe Ulcerative Colitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Ulcerative Colitis

Interventions

DRUG

Visilizumab

Trial Locations (7)

Mayo Clinic, Rochester

University of California, San Francisco

Cedars-Sinai Medical Center, Los Angeles

Atlanta Gastroenterology Associates, Atlanta

The University of Chicago Medical Center, Chicago

Mount Sinai School of Medicine, New York

University of Pittsburgh School of Medicine, Pittsburgh